Blood cancer

Israeli-American Gamida hits goal in phase 3 blood cancer trial

The company uses umbilical cord blood, which like bone marrow and peripheral blood, is a rich source of stem cells for transplantation.

By MAAYAN JAFFE-HOFFMAN

Tel Aviv University researchers (from left): Dr. Yaron Carmi, Diana Rasuluniriana, Dr. Peleg Ride

Israeli blood cancer treatment could also kill solid tumors - new study

Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.

By MAAYAN JAFFE-HOFFMAN

Hot Opinion

No, Mr. Netanyahu, the Israeli media is not like North Korea's By JPOST EDITORIAL

Global chaos is breeding antisemitism. Global leaders must end it By SIMA VAKNIN-GILL

At 20, Bashar Assad's rule is the shame of the Arab world By AMOTZ ASA-EL

Education, not censorship, must be used to tackle online antisemitism By EMILY SCHRADER

Is COVID-19 the death of the synagogue? By MICAH HALPERN

The Jerusalem Post Customer Service Center can be contacted with any questions or requests: Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056 Fax: 03-5613699E-mail: subs@jpost.com The center is staffed and provides answers on Sundays through Thursdays between 07:00 and 14:00 and Fridays only handles distribution requests between 7:00 and 13:00 For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 6PM Toll Free number in Israel only 1-800-574-574 Telephone +972-3-761-9056 Fax: 972-3-561-3699 E-mail: subs@jpost.com

Most Read

Hot Opinion